Cardiac followed by autologous stem cell transplantation for systemic AL amyloidosis.

被引:0
|
作者
Gillmore, JD [1 ]
Wechalekar, AD [1 ]
Goodmarn, HJB [1 ]
Lachmann, HJ [1 ]
Offer, M [1 ]
Joshi, J [1 ]
Hawkins, RN [1 ]
机构
[1] Royal Free & UCL Med Sch, Natl Amyloidsis Ctr, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1158
引用
收藏
页码:338A / 338A
页数:1
相关论文
共 50 条
  • [11] Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation
    Jolanta B. Perz
    Arnt V. Kristen
    Amin Rahemtulla
    Jayan Parameshwar
    Falk-Udo Sack
    Jane F. Apperley
    Hartmut Goldschmidt
    Hugo A. Katus
    Thomas J. Dengler
    Clinical Research in Cardiology, 2006, 95 : 671 - 674
  • [12] Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis
    Carretero, Marcelina
    Villanueva, Eugenia
    Brulc, Erika B.
    Faelo, Franco M.
    Aguirre, Maria A.
    Perez-de-Arenaza, Diego
    Belziti, Cesar A.
    Arbelbide, Jorge A.
    Nucifora, Elsa M.
    Posadas-Martinez, Maria L.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (04): : 435 - 441
  • [13] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [14] The role of renal transplantation in systemic AL amyloidosis.
    Wechalekar, AD
    Lachmann, HJ
    Gillmore, JD
    Goodman, HJB
    Offer, M
    Hawkins, PN
    BLOOD, 2005, 106 (11) : 976A - 977A
  • [15] Autologous stem cell transplantation in primary systemic amyloidosis.: Results in 34 patients from a single centre
    Blade, J.
    Rovira, M.
    Esteve, J.
    Cibeira, M. T.
    Rosinol, L.
    Fernandez-Aviles, F.
    Salamero, O.
    Martinez, C.
    Marin, P.
    Montserrat, E.
    Carreras, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S64 - S64
  • [16] Autologous stem cell transplantation for primary systemic amyloidosis
    Comenzo, RL
    Gertz, MA
    BLOOD, 2002, 99 (12) : 4276 - 4282
  • [17] Renal outcome in dose-intensive melphalan therapy and autologous stem cell transplantation for AL amyloidosis.
    Meier, P
    Bakr, M
    Frossard, V
    Rosselet, A
    Kovacsovics, T
    Burnier, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 669A - 669A
  • [18] AUTOLOGOUS STEM-CELL TRANSPLANTATION IN AMYLOIDOSIS AL
    MAJOLINO, I
    MARCENO, R
    PECORARO, G
    SCIME, R
    VASTA, S
    LIBERTI, G
    RIZZO, A
    INDOVINA, A
    CARONIA, F
    BONE MARROW TRANSPLANTATION, 1993, 11 (01) : 85 - 85
  • [19] Long term renal outcome of peripheral blood stem cell transplantation on primary systemic (AL) amyloidosis.
    Villicana, R
    Leung, N
    Gertz, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 459A - 460A
  • [20] Baseline serum albumin and proteinuria predict renal response after autologous stem cell transplantation in AL amyloidosis.
    Leung, N
    Dispenzieri, A
    Lacy, MQ
    Litzow, MR
    Kumar, SK
    Hayman, SR
    Gertz, MA
    BLOOD, 2005, 106 (11) : 340A - 341A